Everyone has a favourite Shark on Shark Tank India, but ask any entrepreneur who they most want in their corner — and Namita Thapar keeps coming up. The Executive Director of Emcure Pharmaceuticals doesn’t just write cheques. She rolls up her sleeves, mentors founders, and has built a portfolio of startups that are genuinely changing the game. Here’s a look at her best bets — and how they’ve grown since leaving the Tank.
Table of Contents
Namita Thapar’s Top Shark Tank India Investments
| Startup | Sector | Deal | Post-Show Growth |
|---|---|---|---|
| Skippi Ice Pops | F&B | ₹20L for 3% equity | 2900% ROI; valuation hit ₹6 Cr |
| Bummer | D2C Apparel | ₹75L for 7.5% | Revenue grew 18x to ₹11 Cr in 2 years |
| Janitri | HealthTech | ₹1 Cr for 2.5% equity | Revenue grew 7x; valuation reached ₹200 Cr |
| Arata | Personal Care | ₹1 Cr for 2% equity | Valuation at ₹75.19 Cr |
| The Bear House | Menswear | ₹3 Cr (equity + debt) | Projected ₹140 Cr revenue with 40% YoY growth |
| Rare Planet | Handicrafts | ₹65L for 1% equity | First-ever partial Shark exit in Shark Tank India history |
Why These Deals Stand Out
Namita isn’t chasing trends — she’s backing purpose. Take Janitri, a healthtech startup focused on maternal and newborn monitoring. At the time of pitching, the founder highlighted that 80% of maternal and newborn deaths could be prevented with proper monitoring. Namita saw the mission, backed the team, and the result? Sales grew 7 times after the deal, reaching an estimated ₹7–8 crore in revenue, with the company targeting a Series A round at a valuation 5 times higher, making it worth ₹200 crore.
Then there’s The Bear House, which may be her most talked-about recent deal. The brand is expected to cross ₹140 crore in net revenue with over 40% year-on-year growth Rangeeladancecompany — extraordinary by any standard. And when Aman Gupta himself calls a brand “too good to be true,” you know something special is happening.
Across all seasons, Namita has invested in over 100 startups via Shark Tank India Bollyserial, maintaining close mentoring relationships with founders long after cameras stop rolling. Her net worth stands at an estimated ₹600 crore, with her portfolio spanning pharma, D2C, health, and fashion.
For more startup funding updates, Shark Tank India recaps, and business entertainment coverage, visit TechnoSports Entertainment.
FAQs
Q: What is Namita Thapar’s best investment on Shark Tank India?
Rare Planet stands out as her most historic deal — she became the first Shark ever to execute a successful partial exit in Shark Tank India history, in January 2024.
Q: Who is Namita Thapar and what company does she lead?
Namita Thapar is the Executive Director of Emcure Pharmaceuticals and one of the most prominent Sharks on Shark Tank India, known for backing health and consumer startups.
